Literature DB >> 10827175

TIMP-2 is required for efficient activation of proMMP-2 in vivo.

Z Wang1, R Juttermann, P D Soloway.   

Abstract

Matrix metalloproteinases (MMPs) are synthesized as latent proenzymes. A proteolytic cleavage event involving processing of the cysteine-rich N-terminal propeptide is required for their full activation. Previous in vitro studies indicated that activation of proMMP-2 can occur through formation of a trimolecular complex between MMP-14, TIMP-2, and proMMP-2 at the cell surface. Using TIMP-2-deficient mice and cells derived from them, TIMP-2 was shown to be required for efficient proMMP-2 activation both in vivo and in vitro. The requirement for TIMP-2 was not cell-autonomous as exogenously added TIMP-2 could restore activation of proMMP-2 to TIMP-2-deficient cells. Mutant mice were overtly normal, viable, and fertile on the C57BL/6 background, indicating that both TIMP-2 and activated proMMP-2 are dispensable for normal development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827175      PMCID: PMC2683068          DOI: 10.1074/jbc.M001270200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.

Authors:  E Morgunova; A Tuuttila; U Bergmann; M Isupov; Y Lindqvist; G Schneider; K Tryggvason
Journal:  Science       Date:  1999-06-04       Impact factor: 47.728

2.  Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros.

Authors:  J Barasch; J Yang; J Qiao; P Tempst; H Erdjument-Bromage; W Leung; J A Oliver
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

3.  Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion.

Authors:  N Ramos-DeSimone; E Hahn-Dantona; J Sipley; H Nagase; D L French; J P Quigley
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

4.  The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.

Authors:  G S Butler; M J Butler; S J Atkinson; H Will; T Tamura; S Schade van Westrum; T Crabbe; J Clements; M P d'Ortho; G Murphy
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

5.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice.

Authors:  R D Hautamaki; D K Kobayashi; R M Senior; S D Shapiro
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

6.  Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV.

Authors:  C M Overall; A E King; D K Sam; A D Ong; T T Lau; U M Wallon; Y A DeClerck; J Atherstone
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

7.  Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Authors:  C Fernandez-Catalan; W Bode; R Huber; D Turk; J J Calvete; A Lichte; H Tschesche; K Maskos
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

8.  In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

Authors:  L Guedez; W G Stetler-Stevenson; L Wolff; J Wang; P Fukushima; A Mansoor; M Stetler-Stevenson
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

9.  Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.

Authors:  K Shofuda; K Moriyama; A Nishihashi; S Higashi; H Mizushima; H Yasumitsu; K Miki; H Sato; M Seiki; K Miyazaki
Journal:  J Biochem       Date:  1998-08       Impact factor: 3.387

10.  The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.

Authors:  H Stanton; J Gavrilovic; S J Atkinson; M P d'Ortho; K M Yamada; L Zardi; G Murphy
Journal:  J Cell Sci       Date:  1998-09       Impact factor: 5.285

View more
  102 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 2.  Proteases at the endometrial-trophoblast interface: their role in implantation.

Authors:  Lois A Salamonsen; Guiying Nie
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

Review 3.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

4.  Immobilizing reporters for molecular imaging of the extracellular microenvironment in living animals.

Authors:  Zuyong Xia; Yun Xing; Jongho Jeon; Young-Pil Kim; Jessica Gall; Anca Dragulescu-Andrasi; Sanjiv S Gambhir; Jianghong Rao
Journal:  ACS Chem Biol       Date:  2011-08-23       Impact factor: 5.100

Review 5.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

6.  Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.

Authors:  Masayuki Shimoda; Simona Principe; Hartland W Jackson; Valbona Luga; Hui Fang; Sam D Molyneux; Yang W Shao; Alison Aiken; Paul D Waterhouse; Christina Karamboulas; Franz M Hess; Takashi Ohtsuka; Yasunori Okada; Laurie Ailles; Andreas Ludwig; Jeffrey L Wrana; Thomas Kislinger; Rama Khokha
Journal:  Nat Cell Biol       Date:  2014-08-24       Impact factor: 28.824

7.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro.

Authors:  Gentian Lluri; Garret D Langlois; Paul D Soloway; Diane M Jaworski
Journal:  Exp Cell Res       Date:  2007-06-27       Impact factor: 3.905

8.  Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma.

Authors:  Shohei Koyama
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

9.  The cytoplasmic tail dileucine motif LL572 determines the glycosylation pattern of membrane-type 1 matrix metalloproteinase.

Authors:  Thomas Ludwig; Sarah M Theissen; Michael J Morton; Michael J Caplan
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

10.  The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos.

Authors:  Jinsong Zhang; Shan Bai; Carmen Tanase; Hideaki Nagase; Michael P Sarras
Journal:  Dev Genes Evol       Date:  2003-05-08       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.